Physician profile
Dwayne L Platt
NPI 1912908047
$976.67
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $125 · 2021: $150 · 2022: $250.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $317.63 | 2019-2022 | |
| Pfizer INC. | $207.55 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $125.00 | 2022 | |
| Glaxosmithkline, LLC. | $61.56 | 2019 | |
| Amgen INC. | $41.50 | 2019 | |
| Allergan, INC. | $40.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $27.01 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.50 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.84 | 2019 | |
| Amarin Pharma, INC. | $23.52 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.02 | 2019 | |
| Merck Sharp & Dohme LLC | $13.92 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.78 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.39 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.98 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $11.40 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Platt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.